AIM ImmunoTech Inc.
AIM
$0.29
-$0.02-5.79%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.23% | 4.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.23% | 4.00% | |||
| Cost of Revenue | -41.18% | 580.00% | |||
| Gross Profit | 54.76% | -380.00% | |||
| SG&A Expenses | 7.56% | 20.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.22% | -7.41% | |||
| Operating Income | -20.64% | 7.52% | |||
| Income Before Tax | -27.13% | -17.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.13% | -17.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.13% | -17.54% | |||
| EBIT | -20.64% | 7.52% | |||
| EBITDA | -21.56% | 7.64% | |||
| EPS Basic | 7.64% | 57.37% | |||
| Normalized Basic EPS | 52.04% | 17.64% | |||
| EPS Diluted | 7.64% | 57.37% | |||
| Normalized Diluted EPS | 52.04% | 17.64% | |||
| Average Basic Shares Outstanding | 37.66% | 175.72% | |||
| Average Diluted Shares Outstanding | 37.66% | 175.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||